Johnson & Johnson (NYSE:JNJ) research and developer of healthcare products, is expected to report second quarter earnings results, before market open, on Thursday 16th July 2020.
Analysts polled by Thomson Reuters anticipate second quarter income of $ 1.48 per share.
Looking ahead, the full year income are expected at $ 7.73 per share on the revenues of $ 79535.50 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 77,500.00 million ~ $ 80,500.00 million, where as bottomline are predicted in a range of $ 7.50 ~ $ 7.90 per share
Click Here For More Historical Outlooks Of Johnson & Johnson
Previous Quarter Performance
Johnson & Johnson announced income for the first quarter of $ 2.17 per share, from the revenue of $ 20,691.00 million, On adjusted basis, JNJ reported income for the quarter of $ 2.30 per share. The quarterly earnings swell 56.12 percent while revenues extended 3.35 percent compared with the same quarter last year. The consensus estimates are income of $ 1.99 per share from $ 19478.90 million in revenue. The bottom line results beat street analysts by $ 0.31 or 15.58 percent, at the same time, top line results outshined analysts by $ 1,212.10 million or 6.22 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Johnson & Johnson
Stock Performance
According to the previous trading day, closing price of JNJ was $ 139.77, representing a 28.04 % increase from the 52 week low of $ 109.16 and a 9.53 % decrease over the 52 week high of $ 154.50.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”JNJ” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Recent Stock Dividend Announcement
On April 14, 2020, the board of directors authorized quarterly dividend of $ 1.01 per share to holders of record as of the close of business on May 26, 2020, with payment date of June 9, 2020 and ex-dividend date on May 22, 2020.
Conference Call
Johnson & Johnson will be hosting a conference call at 8:00 AM eastern time on 16th July 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.jnj.com
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSONS brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.
